Congress Park Capital’s Thermo Fisher Scientific TMO Stock Holding History

Congress Park Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$815K	Buy	1,625 +63	+4%	+$30.2K	0.22%	73
2026 Q1	$768K	Buy	1,562 +335	+27%	+$182K	0.24%	70
2025 Q4	$711K	Buy	1,227 +2	+0.2%	+$1.13K	0.21%	75
2025 Q3	$594K	Buy	1,225 +175	+17%	+$81.5K	0.18%	76
2025 Q2	$426K	Buy	+1,050	New	+$439K	0.14%	83
2024 Q1	–	Sell	-650	Closed	-$345K	–	124
2023 Q4	$345K	Buy	+650	New	+$315K	0.17%	91
2023 Q2	–	Sell	-450	Closed	-$259K	–	136
2023 Q1	$259K	Sell	450 -100	-18%	-$56.4K	0.13%	108
2022 Q4	$303K	Buy	550 +85	+18%	+$45K	0.18%	99
2022 Q3	$236K	Buy	+465	New	+$260K	0.14%	111

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Congress Park Capital's TMO Position: Q2 2026 in Review

Congress Park Capital increased its Thermo Fisher Scientific (TMO) stake by 4% in Q2 2026, buying an estimated $30.2K and bringing the position to 1,625 shares worth $815K. The position accounts for 0.22% of the portfolio, ranked #73.

Congress Park Capital first reported a position in TMO in Q3 2022 and has held it in 9 quarters since. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Congress Park Capital held 1,625 shares of Thermo Fisher Scientific worth $815K as of Q2 2026.
Congress Park Capital bought 63 Thermo Fisher Scientific shares in Q2 2026, an estimated $30.2K.
Thermo Fisher Scientific made up 0.22% of Congress Park Capital's portfolio in Q2 2026, its #73 holding.
Congress Park Capital first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 9 quarters since.
1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Congress Park Capital's 13F filing for Q2 2026, filed 14 Jul 2026.